Role of maternal, fetal and placental histopathology factors in the pathogenesis of retinopathy of prematurity

Purpose To investigate if maternal, fetal and placental vascular and/or molecular changes predict the risk for retinopathy of prematurity in preterm infants. Methodology The postnatal and antenatal data and placental histopathological changes; H&E staining of placental sections and molecular findings; gene expression analysis by qRT-PCR and protein expression by IHC at the maternal-fetal interface were collected from 20 placental samples and categorized into 3 groups: full-term (n=10), preterm without ROP (n=7) and preterm with ROP (n=6). Results The correlation analysis indicated significant association of increased monocytes (p=0.042), fetal growth retardation (p=0.000), apnoeic spell (p=0.033), ventilation (p=0.009), length in hospital stay (p=0.001) and decreased RBC (p=0.02), Hb (p=0.048), PCV (p=0.010), gestational age (p=0.003), birth weight (p=0.000) with increased risk of ROP. Along with these factors, placental weight(p=0.001), diameter (p=0.019), Tenny-Parker changes (p=0.025), alternating area of small and short hyper mature villi (p=0.033) are also found to be significant determinants of the disease. Gene expression analysis revealed significant increase in hypoxia (HIF-1 gene expression; p=0.007) and non-significant increase in the pro-inflammatory marker IL-6. The protein expression also showed the significantly increased activation of complement pathway (CFH) and NF- ΚB at maternal-fetal interface. Conclusions Our preliminary results support the changes in the maternal-fetal factors, placental histopathology and molecular alterations related to hypoxia, inflammation and complement activation at maternal-fetal interface in preterm with ROP placentas. These changes have the potential to predict the risk of the disease but the results are required to be further validated in larger cohort.

[1]  Bin Liang,et al.  Effects of Nrf-2 expression in trophoblast cells and vascular endothelial cells in preeclampsia. , 2021, American journal of translational research.

[2]  M. Shapiro,et al.  Aggressive Posterior Retinopathy of Prematurity (APROP) , 2017 .

[3]  P. Sonveaux,et al.  Adaptations of the human placenta to hypoxia: opportunities for interventions in fetal growth restriction. , 2020, Human reproduction update.

[4]  M. Sim,et al.  Prenatal intrauterine growth restriction and risk of retinopathy of prematurity , 2020, Scientific Reports.

[5]  S. Fleming,et al.  Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond , 2020, Frontiers in Immunology.

[6]  S. Sarpal,et al.  Retrospective Analysis of Risk factors in Aggressive Posterior Retinopathy of Prematurity (APROP) , 2020, Delhi Journal of Ophthalmology.

[7]  Subeen Hong,et al.  Immune and Inflammatory Proteins in Cord Blood as Predictive Biomarkers of Retinopathy of Prematurity in Preterm Infants. , 2019, Investigative ophthalmology & visual science.

[8]  Yan Zhao,et al.  Placental weight and size in relation to fetal growth restriction: a case-control study , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[9]  B. Stoll,et al.  Associations Between the Features of Gross Placental Morphology and Birthweight , 2018, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[10]  H. Fox,et al.  Pathology of the Placenta , 2019, Springer International Publishing.

[11]  B. Huppertz The Critical Role of Abnormal Trophoblast Development in the Etiology of Preeclampsia , 2018, Current pharmaceutical biotechnology.

[12]  Sonika C. Rathi,et al.  Abnormal Complement Activation and Inflammation in the Pathogenesis of Retinopathy of Prematurity , 2017, Front. Immunol..

[13]  S. Fleming,et al.  The Complement System and Preeclampsia , 2017, Current Hypertension Reports.

[14]  T. Greene,et al.  Association of Maternal Preeclampsia With Infant Risk of Premature Birth and Retinopathy of Prematurity , 2017, JAMA ophthalmology.

[15]  Cassie A. Ludwig,et al.  The Epidemiology of Retinopathy of Prematurity in the United States. , 2017, Ophthalmic surgery, lasers & imaging retina.

[16]  K. Yusuf,et al.  Pre-eclampsia and the risk of retinopathy of prematurity in preterm infants with birth weight <1500 g and/or <31 weeks’ gestation , 2017, BMJ Open Ophthalmology.

[17]  Neil J Sebire,et al.  Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. , 2016, Archives of pathology & laboratory medicine.

[18]  F. Gaccioli,et al.  Placental Nutrient Transport and Intrauterine Growth Restriction , 2016, Front. Physiol..

[19]  E. Alimanović-Halilović,et al.  Risk Factors for Retinopathy of Prematurity in Premature Born Children , 2015, Medical archives.

[20]  R. Burwick,et al.  The complement system and adverse pregnancy outcomes. , 2015, Molecular immunology.

[21]  Johannes E. Schindelin,et al.  The ImageJ ecosystem: An open platform for biomedical image analysis , 2015, Molecular reproduction and development.

[22]  Tao Li,et al.  Serum concentrations of cytokines in infants with retinopathy of prematurity , 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[23]  M. Kirschfink,et al.  Complement Profile in Neonates of Different Gestational Ages , 2014, Scandinavian journal of immunology.

[24]  H. Su,et al.  Inflammatory markers in cord blood or maternal serum for early detection of neonatal sepsis—a systemic review and meta-analysis , 2014, Journal of Perinatology.

[25]  R. Touyz,et al.  Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. , 2013, Antioxidants & redox signaling.

[26]  K. Park,et al.  The relationship between cord blood cytokine levels and perinatal factors and retinopathy of prematurity: a gestational age-matched case-control study. , 2013, Investigative ophthalmology & visual science.

[27]  R. Menon Preterm birth: a global burden on maternal and child health , 2012, Pathogens and global health.

[28]  J. Kingdom,et al.  Distal villous hypoplasia , 2012 .

[29]  Cathleen K. Yoshida,et al.  Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study , 2011, Molecular autism.

[30]  P. Hardy,et al.  Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. , 2010, The Journal of clinical investigation.

[31]  Frank Rose,et al.  HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. , 2010, Free radical biology & medicine.

[32]  M. Ares,et al.  Purification of RNA using TRIzol (TRI reagent). , 2010, Cold Spring Harbor protocols.

[33]  A. Vinekar,et al.  National Neonatology Foundation's Evidence Based Clinical Practice Guidelines for Retinopathy of Prematurity, NNF India, Guidelines , 2010 .

[34]  A. Gerinec,et al.  Retinopathy of prematurity--epidemics, incidence, prevalence, blindness. , 2010, Bratislavske lekarske listy.

[35]  N. Kanayama,et al.  Chorangiosis and placental oxygenation , 2009, Congenital anomalies.

[36]  Y. Sadovsky,et al.  The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro. , 2008, Placenta.

[37]  A. Fischer,et al.  Cutting sections of paraffin-embedded tissues. , 2008, CSH protocols.

[38]  A. Fischer,et al.  Hematoxylin and eosin staining of tissue and cell sections. , 2008, CSH protocols.

[39]  Charles E. Riva,et al.  Regulation of retinal blood flow in health and disease , 2008, Progress in Retinal and Eye Research.

[40]  G. Holmström,et al.  Long-term follow-up of visual functions in prematurely born children--a prospective population-based study up to 10 years of age. , 2008, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[41]  I. Crocker,et al.  Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species. , 2007, Placenta.

[42]  W. Carlo,et al.  Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of neonatal morbidity. , 2004, American journal of obstetrics and gynecology.

[43]  T. Stallmach,et al.  Placental pathology: its impact on explaining prenatal and perinatal death , 2003, Virchows Archiv.

[44]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .

[45]  I. Casteels,et al.  Perinatal growth characteristics and associated risk of developing threshold retinopathy of prematurity. , 2003, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[46]  D. Charnock-Jones,et al.  Placental vascular morphogenesis. , 2000, Bailliere's best practice & research. Clinical obstetrics & gynaecology.

[47]  J. Jośko,et al.  Vascular endothelial growth factor (VEGF) and its effect on angiogenesis. , 2000, Medical science monitor : international medical journal of experimental and clinical research.

[48]  S. Fisher,et al.  Invasive cytotrophoblast apoptosis in pre-eclampsia. , 1999, Human reproduction.

[49]  A. Filouš,et al.  [Retinopathy of prematurity]. , 1998, Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti.

[50]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[51]  R. O. Poyton,et al.  Oxygen sensing and molecular adaptation to hypoxia. , 1996, Physiological reviews.

[52]  M. Goldberg,et al.  Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*) , 1995, The Journal of Biological Chemistry.

[53]  M. Goldberg,et al.  Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. , 1988, Science.

[54]  G. Altshuler Chorangiosis. An important placental sign of neonatal morbidity and mortality. , 1984, Archives of pathology & laboratory medicine.